- Report
- December 2024
- 30 Pages
Global
From €2462EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2462EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2462EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2462EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2910EUR$3,250USD£2,533GBP
- Report
- December 2024
- 30 Pages
Global
From €2910EUR$3,250USD£2,533GBP
- Report
- December 2024
- 67 Pages
Global
From €3537EUR$3,950USD£3,078GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1119EUR$1,250USD£974GBP
- Report
- October 2024
- 244 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 169 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 138 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 210 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 203 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 212 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 318 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 170 Pages +
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 160 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 331 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 237 Pages
Global
From €7119EUR$7,950USD£6,196GBP
- Report
- October 2024
- 249 Pages
Global
From €7119EUR$7,950USD£6,196GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more